Monday (29.10.2018)

07:30 – 09:00

Scientific Session Advanced Stages

  • Peter Johnson
  • Volker Diehl
  • ECHELON1 Update

    • John Radford
  • HD18 Update

    • Peter Borchmann
  • LYSA AHL2011 Phase III Study

    • Olivier Casasnovas

09:15 – 10:15

Celgene GmbH Satellite Symposium Sponsored Session 6

10:30 – 12:00

Scientific Session Pediatric HL

  • Kara Kelly
  • Christine Mauz-Körholz
  • PD1/-L1 Expression in Pediatric HL

  • Genotyping in Familial HL

  • Functional and Financial outcomes after Treatment for Pediatric Hodgkin Lymphoma

12:15 – 13:45

Merck & Co, Inc. Satellite Symposium Sponsored Session 7

14:00 – 15:30

Scientific Session Immunotherapy – Clinical

  • Martin Hutchings
  • James Armitage
  • Checkmate 205: Cohort D

    • Stephen Ansell
  • GHSG NIVAHL Phase II Trial

    • Paul Bröckelmann

15:30 – 16:00

Main Program Poster Walk

16:00 – 17:30

Scientific Session Relapsed/Refractory HL

  • Anna Sureda
  • Craig H. Moskowitz
  • Transplant BRaVE : Phase II trial

    • Anton Hagenbeek
  • Novel Agents in First Line Salvage

    • Ranjana Advani

17:30

Main Program Closing Remarks

ISHL11 Preliminary Program

ISHL11 Preliminary Program